Recent Posts
- Hikma v. Vanda: Oral Argument Recap
- Teva v. Lilly should not be read as creating a new 112 rule for method of use claims
- Should ANDA filers be using the PTAB to mount early challenges to OB patents?
- Switching to WordPress
- Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases
Category: Conferences
-
McAndrews Shareholder Sandra Frantzen will be one of the featured speakers at American Conference Institute's "Summit on U.S. Biosimilars" conference in Munich, Germany, April 20-21. Ms. Frantzen will be speaking on "Incorporating Inter-Partes Review and New USPTO Procedures into Branded and Biosimilar Litigation Strategies." Other speakers include in-house counsel and executives from AbbVie, Boehringer Ingelheim,…
-
ACI's "Paragraph IV Disputes Master Symposium" returns to Chicago next week, September 30 to October 1. According to ACI, this is an "advanced forum for brand name and generic counsel on the intricacies of Hatch-Waxman litigation." The agenda includes the following presentations: Review of Key Supreme Court Cases that May Alter the Course of Paragraph…
-
We are proud that McAndrews Shareholder Nabeela Rasheed will be one of the featured speakers at American Conference Institute's inaugural "Women Leaders in Life Sciences Law" conference in Boston, July 28-29. Dr. Rasheed will be speaking on "Thinking Like a Leader: Updates on the Substantive Legal Developments Affecting Life Sciences Companies in 2014 and Beyond."…
-
A group of twelve attorneys from McAndrews, Held & Malloy will be attending BIO 2014 in San Diego this week, and we're hosting a cocktail reception on Tuesday night. Please join us if you'll be attending BIO!
-
American Conference Institute will be holding its 2nd annual "Legal and Regulatory Summit on Generic Drugs" in New York on July 24-25. The conference promises to present "comprehensive strategies for the generic pharmaceutical industry's present and future challenges." Here is the complete agenda: Unearthing Changes at the Office of Generic Drugs and Understanding Their Impact…
-
American Conference Institute is holding their 5th annual "Biosimilars" conference in New York on June 5-6. Speakers include in-house counsel from Eli Lilly, Mylan, Sandoz, Amgen, AbbVie, Momenta, J&J, and Actavis. Also speaking will be representatives of the Federal Trade Commission, GPhA, and PhRMA. The agenda includes the following presentations: Minimizing the Uncertainty Surrounding the…
-
American Conference Institute will be holding their 8th annual "Paragraph IV Disputes" conference on April 28-29 in New York. Highlights of the conference include a district court judges panel, a magistrate judges panel, and an FTC keynote address. Here is the complete agenda: On the 30th Anniversary of the Drug Price Competition and Patent Term…
-
Bloomberg BNA's upcoming "AIA Post-Grant Patent Practice Conference" presents a unique opportunity to hear from present and former PTAB judges–as well as keynote speakers Hon. Pauline Newman and Hon. Randall Rader. This two-day conference is based on the Bloomberg BNA treatise Post-Grant Patent Practice, which was authored by four former Administrative Patent Judges and which…
-
CPhI will be presenting its 3rd annual "Pharma IPR India" conference in Mumbai on February 26-28. The conference features speakers from more than a dozen different countries across the world. The complete agenda is as follows: Day 1: USA, Canada, and Mexico Analysing the scope and implications of Inter Partes Review (IPR) in the United…
-
ACI is holding its 3rd annual "Patent Reform" conference in New York City next month, on January 22-23. This is the "critical industry forum on the Leahy-Smith America Invents Act." The conference includes the following presentations: USPTO Keynote Address I: The USPTO's Efforts to Implement AIA Provisions Impacting Patent Prosecution Straddling the First-to-Invent/First-to-File Gap: Changing…
Orange Book Blog 